A Resource for Healthcare and Social Services Professionals
February 1, 2023
4:00 pm–8:00 pm ET
This two-part training, formerly known as the 8-hour X-Waiver training, is intended to provide eight hours of training for providers seeking to prescribe buprenorphine.
Via Zoom
This eight-hour course prepares physicians, advanced practice nurses, and physician assistants to prescribe buprenorphine to treat opioid use disorder in their office and in the ED setting. The curriculum includes the science of addiction as a brain disorder, the pharmacology of buprenorphine, and the regulatory requirements around prescribing this medication. Attendees will learn to screen patients for treatment with buprenorphine and to manage the medication along with the patient's other medical needs in an office setting such as a primary care clinic.
Physicians (MD, DO), Nurse Practitioners, Certified Nurse Midwives (CNM), Clinical Nurse Specialists (CNS), Certified Registered Nurse Anesthetists (CRNA), and Physician Assistants
Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS).
American Academy of Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this waiver training.
Funding for this initiative was made possible (in part) by grant no. 6H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
For more information, visit www.pcssNOW.org
Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health , the Bureau of Substance Abuse Services and American Academy of Addiction Psychiatry. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credential Center (ANCC) to provide continuing education for the healthcare team.
In 2020, AAAP also added accreditation from The American Academy of PAs (AAPA), American Psychological Association (APA), Association for Social Work Boards (ASWB) and American Dental Association (ADA).
Physician Designation Statement: American Academy of Addiction Psychiatry designates this live activity for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Designation Statement: American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP's Joint Accreditation provider #4008192. This program is approved for up to 8 Nursing Contact Hours.
PA Designation Statement: American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for a maximum of 8 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Disclosures: AAAP's CE program aims to provide educational information that is balanced, independent, objective and free of bias and based on evidence. In order to resolve any identified Conflicts of Interest, disclosure information from all series planners and speakers is provided during the planning process to ensure resolution of any identified conflicts. The following PCSS, presenters, CPD Committee, and AAAP staff members have reported that they have no commercial relationships relevant to the content of this activity to disclose: Stephen Wyatt, DO; Sanchit Maruti, MD; Thomas Penders, MD; Michael Goedde, MD; Kevin Sevarino, MD, PhD; Nitigna Desai, MD; Colleen Labelle, MSN, RN-BC, CARN; Kathryn Cates-Wessel, Seth Acton, Sherly Charles and Erin Waters.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.